ArticleSignal transduction and targeted therapy2023

Pyrotinib plus capecitabine could significantly improve overall survival in HER2-positive metastatic breast cancer.

Xiuwen Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.